Practiceby Lab 10 Get started ›
Crossfire

Is the 10 percent cap on saturated fat worth following?

What the experts say

Joel KahnMD · cardiologist; MD and Michigan licence confirmed in NPPES, stated triple board certification in internal medicine, cardiovascular medicine and interventional cardiology not confirmed against any certifying body

Yes. Keep saturated fat low, which in practice means cutting animal foods and tropical oils, because that is what the expert panels still say.

What it rests onHe assembles the current published saturated-fat position of thirteen named bodies including the WHO (under 10 percent of energy, replace with polyunsaturated fat), the American Heart Association (under 6 percent for people reducing cardiovascular risk), the European Society of Cardiology, the American College of Cardiology, the Academy of Nutrition and Dietetics, the American Diabetes Association and the American Academy of Pediatrics, and concludes that his centre will continue to teach diets lower in saturated fat on the strength of what he describes as 70 years of data in hundreds of studies. His argument is that the consensus holds, not that any single trial settles it.

Source: kahnlongevitycenter.com ↗
Nina TeicholzPhD · investigative science journalist and author

No. Stop treating the 10 percent cap as an evidence-based number.

What it rests onHer case is historiographical and evidentiary at once: the cap traces to the American Heart Association's 1961 advice and the 1977 McGovern report, neither resting on trial evidence; the randomised trials of the 1960s and 1970s tested the hypothesis in roughly 67,000 people and lowered cholesterol by an average of 29 mg/dl, indicating compliance, yet most did not show the expected reduction in cardiovascular or total mortality; more than 20 reviews since 2010 have on the whole found no effect of saturated fat on major cardiovascular outcomes or total mortality; and no Dietary Guidelines committee has ever systematically reviewed those core trials directly.

Source: pmc.ncbi.nlm.nih.gov ↗

Overview

Both are addressing general adults, so they are answering the same question, but they are not making the same kind of argument. Kahn's case is institutional agreement: he counts the organisations and reports what they hold. Teicholz's case is that the agreement he counts was manufactured rather than earned, so counting it settles nothing.

Read as 'he says less saturated fat, she says more' this misreads both of them. She is not recommending saturated fat, and he is not defending where the number came from.

Where they agree

Both accept that trans fat is harmful and that the food matrix matters. Both accept that the trials of the 1960s and 1970s exist and were large; they disagree about what those trials showed. Neither is arguing that a specific percentage is biologically magic; Kahn reports three different caps from three different bodies in the same post.

What would settle it

For Kahn, a systematic review of the core diet-heart trials by a guidelines committee, which Teicholz notes has never happened, coming out the way the guidelines assume. For Teicholz, a modern randomised trial with hard endpoints testing saturated fat replacement, which nobody is running. Both sides are arguing about a body of evidence that will not be added to.

Practice does not pick a winner here

You do, and your call is dated, kept, and yours to change. Follow the people you already trust and what they publish turns into a short daily practice.

Get started

Free to sign up and use. We do not ask for a card.